We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare.

As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization’s three priority diseases – HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields.

Brentford, GB
101,192 (est)+3%

Key People at GlaxoSmithKline

Andrew Philip Witty

Andrew Philip Witty

Simon Dingemans

Simon Dingemans

David Redfern

David Redfern

Philip Thomson

Philip Thomson

SVP Global Communications & Government Affairs
Dan Troy

Dan Troy

General Counsel
Emma Walmsley

Emma Walmsley

CEO of GSK Consumer Healthcare

GlaxoSmithKline Locations

Brentford, GB
Cincinnati, US
Dorset, GB
Washington, US
Mexico City, MX
Baku, AZ
Parsippany-Troy Hills, US
Tirana, AL
Boudouaou Est, DZ
Yerevan, AM
Boronia, AU
Wien, AT
Baltimore, US
Bangladesh, IN
Minsk, BY
Wavre, BE
Bogotá, CO
Izmir, TR

GlaxoSmithKline Metrics

GlaxoSmithKline Summary

Market capitalization

$98.2 B

Closing share price


GlaxoSmithKline Financials

FY, 2013FY, 2014FY, 2015


£26.5 B£23 B£23.9 B

Revenue growth, %


Gross profit

£17.9 B£15.7 B£15.1 B

Gross profit Margin, %


Operating expense total

£10.9 B£12.1 B£4.75 B

GlaxoSmithKline Market Value History

GlaxoSmithKline Online Presence

GlaxoSmithKline News

GlaxoSmithKline Company Life